The proven, minimally invasive treatment that fills the gap between prescription medications and more invasive surgical procedures.
Treatment with the UroLift® System is typically a one-time solution that provides rapid relief and recovery of BPH symptoms.1 It can break the cycle of medications and how they make a person feel, all without the risks of more invasive surgery. The goal of the UroLift System treatment is to relieve symptoms so you can get back to your life and resume your daily activities.
The UroLift System treatment has demonstrated a significant improvement in symptoms for patients compared to medications.1,2 The UroLift System is the only leading BPH procedure shown not to cause new and lasting erectile or ejaculatory dysfunction*, while being a safe and effective treatment of lower urinary tract symptoms due to BPH.2-4
The UroLift System uses a minimally invasive approach to treating BPH that lifts and holds the enlarged prostate tissue so it no longer blocks the urethra. The treatment is performed by a urologist and does not require heating, cutting, or removal of the prostate tissue. The procedure is typically performed using local anesthesia in the outpatient clinic or day surgery unit. Patients typically return home the same day without a catheter.1
An enlarged prostate can narrow or even block the urethra.
The UroLift Delivery Device is placed through the obstructed urethra to access the enlarged prostate.
Small UroLift Implants are permanently placed to lift and hold the enlarged prostate tissue out of the way and increase the opening of the urethra.
The UroLift Delivery Device is removed, leaving an open urethra designed to provide symptom relief.
As with any medical procedure, individual results may vary. Speak with your urologist to see if the UroLift System treatment is right for you. Most common side effects are temporary and include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge.1 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention.
Source Information
*No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study
Grosvenor House, Horseshoe Crescent, Old Town, Beaconsfield, Bucks, HP9 1LJ
© 2024 Teleflex Inc. All rights reserved. | Terms of Use | Internet Privacy Policy | Patient Safety | Imprint | Compliance
MCI-2022-0108